嘉必优: 嘉必优生物技术（武汉）股份有限公司关于第二期回购公司股份期限过半尚未实施回购的公告

Core Viewpoint - The company has announced that it has not yet implemented its share repurchase plan, which is now more than halfway through its designated period [1][2]. Group 1: Share Repurchase Plan - The company approved a share repurchase plan with a total fund amount between RMB 15 million and RMB 30 million, with a maximum repurchase price of RMB 25.00 per share [1]. - The upper limit of the repurchase price has been adjusted to RMB 24.80 per share, effective from July 10, 2025 [2]. - As of the announcement date, the company has not executed any repurchases due to considerations of its operational status and market conditions [2]. Group 2: Future Repurchase Arrangements - The company plans to proceed with the share repurchase within the designated period and will adhere to relevant regulations and disclosure obligations [2].